RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)

NCT00443846 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

247

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningitis, Meningococcal
Rotavirus Infections

Interventions

BIOLOGICAL: RotaTeq®
BIOLOGICAL: NeisVac-C®

Sponsor

Merck Sharp & Dohme LLC